Oxitec

Oxitec is a pioneering biotech company that strives to revolutionize pest control for the betterment of public health and agriculture. Established in 2002 and headquartered in the United Kingdom, the company has gained recognition as the leader in biotech solutions for safely and sustainably managing pests that pose significant threats to crop yields, livestock, and disease transmission.

With a diverse team representing 15 countries, Oxitec is devoted to developing groundbreaking, self-limiting technology aimed at eradicating pests without causing harm to non-target species or the environment. Their technology platform enables the creation of species-specific, non-toxic control solutions that have garnered acclaim for their targeted insect suppression, biosafety, regulatory compliance, and scalability.

Recently, the company attracted a substantial $18.00M grant investment from the Bill & Melinda Gates Foundation on 13 April 2022, reinforcing its position as an influential player in the industry. Looking ahead, Oxitec continues to seek passionate individuals who share their vision of making a global impact through their innovative biotech solutions.